cs.AIOct 21, 2026

An Evidence-Driven Multi-Agent Compound AI System for Head and Neck Proton Radiotherapy Planning

Authors: Qingqing Wang, Liqiang Xiao, Chang Chang

Organizations: Department of Radiation Medicine and Applied Sciences, University of California at San Diego, 9500 Gilman Drive, La Jolla, 92093, California, USA · California Protons Cancer Therapy Center, 9730 Summers Ridge Road, San Diego, 92121, California, USA

Abstract

Radiation treatment planning requires balancing competing objectives to satisfy clinical criteria while accommodating physicians' preferences. This study aims to develop an evidence-driven, multi-agent compound AI system that integrates DRL-based automated treatment planning with LLM-based conversational plan refinement for proton PBS therapy. A policy network trained using PPO first generates multiple plans without human intervention, from which one is selected as the target plan and the others serve as references for subsequent refinements. For challenging cases requiring further adjustments, an LLM-based multi-agent system enables plan refinement through natural language interactions. The system comprises a planning agent that recommends evidence-supported adjustments, a chatbot providing a unified conversational interface, and an evaluation agent that retrieves clinical metrics and identifies constraint violations. To enhance domain-specific reasoning, the planning agent based on Qwen3-14B is designed to justify its recommendations using evidence from previously generated plans and post-trained on task-specific data using SFT and GRPO. The framework was trained and evaluated using 21 patients with H&N cancers, with 5 PPO-generated plans per patient. Of these, 50 plans were selected for instruction-guided refinement. Compared with the base LLM, the post-trained Qwen3-14B demonstrated improved instruction-following, information retrieval and domain-specific reasoning capabilities. The resulting adjustments more effectively improved user-prioritized objectives while limiting deterioration in competing objectives, yielding more clinically appropriate trade-offs in patient-specific plan refinement. The proposed compound AI system provides a user-friendly planning platform, offering a promising approach to personalized proton PBS treatment planning.

Figures & tables

Explore similar work

May 30, 2026

A Machine-to-Machine Knowledge-Guided LLM Agent for Generalizable Radiotherapy Treatment Planning

In this work, we propose a prototype machine-to-machine (M2M) knowledge-guided Large Language Model (LLM) framework for automated radiotherapy treatment planning. In the proposed paradigm, Treatment Planning Parameter (TPP) distribution knowledge discovered by a Deep Reinforcement Learning (DRL) agent is transferred to an LLM agent through in-context learning, enabling autonomous iterative planning without human intervention. While standard LLM-based planning often lacks physical intuition and struggles with convergence, the integration of DRL-derived guidance constrains the agent to a physically valid parameter space. Experimental evaluations are performed across three diverse planning scenarios: basic prostate cases, complex prostate configurations with increased organ-at-risk (OAR) constraints, and liver cases. The evaluation results demonstrate that the guided LLM agent consistently achieves optimal planning scores while significantly reducing the number of iterations compared to unguided planning. Analysis of the final TPP configurations reveals that the agent successfully learns a hierarchical priority of objectives, effectively restoring a logical "cause-and-effect" relationship between parameter tuning and dosimetric outcomes. Crucially, this prototype framework exhibits robust generalizability, maintaining high planning quality regardless of specific patient anatomy, treatment site, or initial plan quality. By bridging the specialized optimization of DRL with the adaptive reasoning of LLMs, this M2M framework establishes a scalable foundation towards generalizable autonomous treatment planning, ultimately benefiting clinical practice in realistic environments.
Dec 8, 2025

Demo: Generative AI helps Radiotherapy Planning with User Preference

Radiotherapy planning is a highly complex process that often varies significantly across institutions and individual planners. Most existing deep learning approaches for 3D dose prediction rely on reference plans as ground truth during training, which can inadvertently bias models toward specific planning styles or institutional preferences. In this study, we introduce a novel generative model that predicts 3D dose distributions based solely on user-defined preference flavors. These customizable preferences enable planners to prioritize specific trade-offs between organs-at-risk (OARs) and planning target volumes (PTVs), offering greater flexibility and personalization. Designed for seamless integration with clinical treatment planning systems, our approach assists users in generating high-quality plans efficiently. Comparative evaluations demonstrate that our method can surpasses the Varian RapidPlan model in both adaptability and plan quality in some scenarios.
Sep 30, 2026

An Uncertainty-Guided Digital Twin Framework for Online Adaptive Proton Therapy in Head and Neck Cancer: A Feasibility Study

Objective: Head and neck (HN) proton therapy spans six to seven weeks of anatomical change, while offline replanning takes about a week. We present an uncertainty-guided digital twin (UGDT) framework that forecasts treatment-day anatomy before treatment and evaluate whether it generates online adaptive proton therapy (APT) plans of clinical quality. Approach: A library of 302 longitudinal deformations from 88 previously treated HN patients was transported onto each new patient's treatment planning CT (TPCT) using two-step multi-atlas deformable image registration (DIR) built on a pretrained CT foundation model, generating about 284 predicted CTs (pdCTs) with contours per patient. Dispersion of propagated clinical target volume (CTV) contours defined a patient-specific robust margin. In ten patients, the quality assurance CT (QACT) triggering a replan represented treatment-day anatomy, and the physician-approved replan was the baseline. The pdCT most similar to the QACT (pdCT-H) and one from the lowest quartile (pdCT-L) were planned to within about 5% of baseline plan quality, forward-calculated on the QACT, and reoptimized to generate online APT plans. Main results: pdCT plans scored within -0.7% (pdCT-H) and -1.0% (pdCT-L) of baseline. Forward calculation on QACT reduced high-dose CTV D98% to 88.3% and 85.5%. After online reoptimization, D98% recovered to 98.3 +/- 0.3% and 98.2 +/- 0.3%, versus 98.5 +/- 0.4% at baseline. Spinal cord and brainstem doses remained below tolerance, and plan quality scores were within -1.1% (p = 0.19) and -1.7% (p = 0.01) of baseline. Significance: UGDT generated online APT plans comparable in quality to physician-approved offline replans using anatomy forecast before treatment, enabling a transition from reactive offline replanning toward anticipatory online adaptation.